
### [MONDO:0017341](http://purl.obolibrary.org/obo/MONDO_0017341)
**Label:** rare virus associated tumor

**Subclasses:** [MONDO:0015157](http://purl.obolibrary.org/obo/MONDO_0015157) (human herpesvirus 8-related disorder), [MONDO:0018224](http://purl.obolibrary.org/obo/MONDO_0018224) (hydroa vacciniforme-like lymphoma), [MONDO:0019478](http://purl.obolibrary.org/obo/MONDO_0019478) (adult nodular lymphocyte predominant Hodgkin lymphoma), [MONDO:0019753](http://purl.obolibrary.org/obo/MONDO_0019753) (localized Castleman disease), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0003928](http://purl.obolibrary.org/obo/MONDO_0003928) (uterine corpus myxoid leiomyosarcoma), [MONDO:0018223](http://purl.obolibrary.org/obo/MONDO_0018223) (systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood), [MONDO:0019752](http://purl.obolibrary.org/obo/MONDO_0019752) (pediatric Castleman disease), [MONDO:0016283](http://purl.obolibrary.org/obo/MONDO_0016283) (leiomyosarcoma of the cervix uteri), [MONDO:0019472](http://purl.obolibrary.org/obo/MONDO_0019472) (extranodal nasal NK/T cell lymphoma), [MONDO:0002159](http://purl.obolibrary.org/obo/MONDO_0002159) (fallopian tube leiomyosarcoma), [MONDO:0019471](http://purl.obolibrary.org/obo/MONDO_0019471) (adult T-cell leukemia/lymphoma), [MONDO:0003369](http://purl.obolibrary.org/obo/MONDO_0003369) (vagina leiomyosarcoma), [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0003367](http://purl.obolibrary.org/obo/MONDO_0003367) (gastric leiomyosarcoma (disease)), [MONDO:0003368](http://purl.obolibrary.org/obo/MONDO_0003368) (prostate leiomyosarcoma), [MONDO:0003365](http://purl.obolibrary.org/obo/MONDO_0003365) (esophagus leiomyosarcoma), [MONDO:0005422](http://purl.obolibrary.org/obo/MONDO_0005422) (nodular sclerosis Hodgkin lymphoma), [MONDO:0003487](http://purl.obolibrary.org/obo/MONDO_0003487) (adenoid squamous cell carcinoma), [MONDO:0003364](http://purl.obolibrary.org/obo/MONDO_0003364) (gallbladder leiomyosarcoma), [MONDO:0003362](http://purl.obolibrary.org/obo/MONDO_0003362) (cutaneous leiomyosarcoma (disease)), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0003360](http://purl.obolibrary.org/obo/MONDO_0003360) (small intestine leiomyosarcoma), [MONDO:0006150](http://purl.obolibrary.org/obo/MONDO_0006150) (colon Burkitt lymphoma), [MONDO:0018628](http://purl.obolibrary.org/obo/MONDO_0018628) (HIV-associated cancer), [MONDO:0018732](http://purl.obolibrary.org/obo/MONDO_0018732) (primary central nervous system lymphoma), [MONDO:0017601](http://purl.obolibrary.org/obo/MONDO_0017601) (diffuse large b-cell lymphoma with chronic inflammation), [MONDO:0019466](http://purl.obolibrary.org/obo/MONDO_0019466) (lymphomatoid granulomatosis), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0009348](http://purl.obolibrary.org/obo/MONDO_0009348) (classic Hodgkin lymphoma), [MONDO:0004626](http://purl.obolibrary.org/obo/MONDO_0004626) (Hodgkin's paragranuloma), [MONDO:0004665](http://purl.obolibrary.org/obo/MONDO_0004665) (Hodgkin's lymphoma, nodular sclerosis), [MONDO:0003378](http://purl.obolibrary.org/obo/MONDO_0003378) (liver leiomyosarcoma), [MONDO:0003379](http://purl.obolibrary.org/obo/MONDO_0003379) (rectum leiomyosarcoma), [MONDO:0003376](http://purl.obolibrary.org/obo/MONDO_0003376) (mediastinum leiomyosarcoma), [MONDO:0003377](http://purl.obolibrary.org/obo/MONDO_0003377) (extrahepatic bile duct leiomyosarcoma), [MONDO:0004620](http://purl.obolibrary.org/obo/MONDO_0004620) (Hodgkin's lymphoma, lymphocytic depletion), [MONDO:0003374](http://purl.obolibrary.org/obo/MONDO_0003374) (larynx leiomyosarcoma), [MONDO:0003372](http://purl.obolibrary.org/obo/MONDO_0003372) (vulvar leiomyosarcoma), [MONDO:0003373](http://purl.obolibrary.org/obo/MONDO_0003373) (kidney leiomyosarcoma), [MONDO:0020330](http://purl.obolibrary.org/obo/MONDO_0020330) (classic Hodgkin lymphoma, lymphocyte-depleted type), [MONDO:0003370](http://purl.obolibrary.org/obo/MONDO_0003370) (retroperitoneal leiomyosarcoma), [MONDO:0003371](http://purl.obolibrary.org/obo/MONDO_0003371) (breast leiomyosarcoma), [MONDO:0020328](http://purl.obolibrary.org/obo/MONDO_0020328) (classic Hodgkin lymphoma, mixed cellularity type), [MONDO:0020329](http://purl.obolibrary.org/obo/MONDO_0020329) (classic Hodgkin lymphoma, lymphocyte-rich type), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0018049](http://purl.obolibrary.org/obo/MONDO_0018049) (Kaposi sarcoma), [MONDO:0019210](http://purl.obolibrary.org/obo/MONDO_0019210) (cutaneous neuroendocrine carcinoma), [MONDO:0016262](http://purl.obolibrary.org/obo/MONDO_0016262) (leiomyosarcoma of the corpus uteri), [MONDO:0003349](http://purl.obolibrary.org/obo/MONDO_0003349) (central nervous system leiomyosarcoma), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003347](http://purl.obolibrary.org/obo/MONDO_0003347) (inflammatory leiomyosarcoma), [MONDO:0021537](http://purl.obolibrary.org/obo/MONDO_0021537) (undifferentiated carcinoma of nasopharynx), [MONDO:0006416](http://purl.obolibrary.org/obo/MONDO_0006416) (small intestinal Burkitt lymphoma), [MONDO:0003348](http://purl.obolibrary.org/obo/MONDO_0003348) (conventional leiomyosarcoma), [MONDO:0020327](http://purl.obolibrary.org/obo/MONDO_0020327) (classic Hodgkin lymphoma, nodular sclerosis type), [MONDO:0004632](http://purl.obolibrary.org/obo/MONDO_0004632) (Hodgkin's granuloma), [MONDO:0004633](http://purl.obolibrary.org/obo/MONDO_0004633) (Hodgkin's lymphoma, mixed cellularity), [MONDO:0004952](http://purl.obolibrary.org/obo/MONDO_0004952) (Hodgkins lymphoma), [MONDO:0005764](http://purl.obolibrary.org/obo/MONDO_0005764) (follicular dendritic cell sarcoma), [MONDO:0003782](http://purl.obolibrary.org/obo/MONDO_0003782) (uterine corpus epithelioid leiomyosarcoma), [MONDO:0021297](http://purl.obolibrary.org/obo/MONDO_0021297) (carcinoma in situ of nasopharynx), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma, susceptibility to, 1), [MONDO:0010762](http://purl.obolibrary.org/obo/MONDO_0010762) (lymphoma, Hodgkin, Y-linked pseudoautosomal), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharyngeal carcinoma), [MONDO:0017347](http://purl.obolibrary.org/obo/MONDO_0017347) (Plasmablastic lymphoma), [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564) (Castleman disease), [MONDO:0017346](http://purl.obolibrary.org/obo/MONDO_0017346) (Epstein-Barr virus-positive diffuse large b-cell lymphoma of the elderly), [MONDO:0017349](http://purl.obolibrary.org/obo/MONDO_0017349) (Myopericytoma), [MONDO:0017348](http://purl.obolibrary.org/obo/MONDO_0017348) (lymphoepithelial-like carcinoma), [MONDO:0017343](http://purl.obolibrary.org/obo/MONDO_0017343) (Epstein-Barr virus-associated malignant lymphoproliferative disorder), [MONDO:0017342](http://purl.obolibrary.org/obo/MONDO_0017342) (Epstein-Barr virus-related tumor), [MONDO:0010273](http://purl.obolibrary.org/obo/MONDO_0010273) (lymphoma, Hodgkin, X-linked pseudoautosomal), [MONDO:0017345](http://purl.obolibrary.org/obo/MONDO_0017345) (Epstein-Barr virus-associated mesenchymal tumor), [MONDO:0017784](http://purl.obolibrary.org/obo/MONDO_0017784) (Epstein-Barr virus-associated gastric carcinoma), [MONDO:0017344](http://purl.obolibrary.org/obo/MONDO_0017344) (Epstein-Barr virus-associated carcinoma), [MONDO:0019088](http://purl.obolibrary.org/obo/MONDO_0019088) (post-transplant lymphoproliferative disease), [MONDO:0004207](http://purl.obolibrary.org/obo/MONDO_0004207) (pulmonary artery leiomyosarcoma), [MONDO:0004604](http://purl.obolibrary.org/obo/MONDO_0004604) (Hodgkin's lymphoma, lymphocytic-histiocytic predominance), [MONDO:0006429](http://purl.obolibrary.org/obo/MONDO_0006429) (splenic Hodgkin lymphoma), [MONDO:0004208](http://purl.obolibrary.org/obo/MONDO_0004208) (superior vena cava leiomyosarcoma), [MONDO:0003358](http://purl.obolibrary.org/obo/MONDO_0003358) (anus leiomyosarcoma), [MONDO:0004206](http://purl.obolibrary.org/obo/MONDO_0004206) (pulmonary vein leiomyosarcoma), [MONDO:0003359](http://purl.obolibrary.org/obo/MONDO_0003359) (myxoid leiomyosarcoma), [MONDO:0003356](http://purl.obolibrary.org/obo/MONDO_0003356) (epithelioid leiomyosarcoma), [MONDO:0003357](http://purl.obolibrary.org/obo/MONDO_0003357) (lung leiomyosarcoma), [MONDO:0003355](http://purl.obolibrary.org/obo/MONDO_0003355) (ovary leiomyosarcoma), [MONDO:0003353](http://purl.obolibrary.org/obo/MONDO_0003353) (heart leiomyosarcoma), [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058) (leiomyosarcoma), [MONDO:0003350](http://purl.obolibrary.org/obo/MONDO_0003350) (granular cell leiomyosarcoma), [MONDO:0003351](http://purl.obolibrary.org/obo/MONDO_0003351) (colon leiomyosarcoma), 

**Mapped go classes:** [GO:0016525](http://purl.obolibrary.org/obo/GO_0016525) (negative regulation of angiogenesis), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0009314](http://purl.obolibrary.org/obo/GO_0009314) (response to radiation), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0043473](http://purl.obolibrary.org/obo/GO_0043473) (pigmentation), [GO:0050679](http://purl.obolibrary.org/obo/GO_0050679) (positive regulation of epithelial cell proliferation), [GO:0032204](http://purl.obolibrary.org/obo/GO_0032204) (regulation of telomere maintenance), [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0021549](http://purl.obolibrary.org/obo/GO_0021549) (cerebellum development), [GO:0000987](http://purl.obolibrary.org/obo/GO_0000987) (proximal promoter sequence-specific DNA binding), [GO:0046983](http://purl.obolibrary.org/obo/GO_0046983) (protein dimerization activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0006974](http://purl.obolibrary.org/obo/GO_0006974) (cellular response to DNA damage stimulus), [GO:0045656](http://purl.obolibrary.org/obo/GO_0045656) (negative regulation of monocyte differentiation), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0006848](http://purl.obolibrary.org/obo/GO_0006848) (pyruvate transport), [GO:0044330](http://purl.obolibrary.org/obo/GO_0044330) (canonical Wnt signaling pathway involved in positive regulation of wound healing), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045786](http://purl.obolibrary.org/obo/GO_0045786) (negative regulation of cell cycle), [GO:0045787](http://purl.obolibrary.org/obo/GO_0045787) (positive regulation of cell cycle), [GO:0097193](http://purl.obolibrary.org/obo/GO_0097193) (intrinsic apoptotic signaling pathway), [GO:0009411](http://purl.obolibrary.org/obo/GO_0009411) (response to UV), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0044337](http://purl.obolibrary.org/obo/GO_0044337) (canonical Wnt signaling pathway involved in positive regulation of apoptotic process), [GO:0044336](http://purl.obolibrary.org/obo/GO_0044336) (canonical Wnt signaling pathway involved in negative regulation of apoptotic process), [GO:0043249](http://purl.obolibrary.org/obo/GO_0043249) (erythrocyte maturation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0051782](http://purl.obolibrary.org/obo/GO_0051782) (negative regulation of cell division), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0031571](http://purl.obolibrary.org/obo/GO_0031571) (mitotic G1 DNA damage checkpoint), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:0021522](http://purl.obolibrary.org/obo/GO_0021522) (spinal cord motor neuron differentiation), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0007007](http://purl.obolibrary.org/obo/GO_0007007) (inner mitochondrial membrane organization), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0003684](http://purl.obolibrary.org/obo/GO_0003684) (damaged DNA binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0010526](http://purl.obolibrary.org/obo/GO_0010526) (negative regulation of transposition, RNA-mediated), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0017154](http://purl.obolibrary.org/obo/GO_0017154) (semaphorin receptor activity), [GO:0002904](http://purl.obolibrary.org/obo/GO_0002904) (positive regulation of B cell apoptotic process), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:2001235](http://purl.obolibrary.org/obo/GO_2001235) (positive regulation of apoptotic signaling pathway), [GO:0007050](http://purl.obolibrary.org/obo/GO_0007050) (cell cycle arrest), [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum), [GO:0090096](http://purl.obolibrary.org/obo/GO_0090096) (positive regulation of metanephric cap mesenchymal cell proliferation), [GO:0006879](http://purl.obolibrary.org/obo/GO_0006879) (cellular iron ion homeostasis), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0051289](http://purl.obolibrary.org/obo/GO_0051289) (protein homotetramerization), [GO:0005669](http://purl.obolibrary.org/obo/GO_0005669) (transcription factor TFIID complex), [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia), [GO:0010332](http://purl.obolibrary.org/obo/GO_0010332) (response to gamma radiation), [GO:0033339](http://purl.obolibrary.org/obo/GO_0033339) (pectoral fin development), [GO:2001022](http://purl.obolibrary.org/obo/GO_2001022) (positive regulation of response to DNA damage stimulus), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0002053](http://purl.obolibrary.org/obo/GO_0002053) (positive regulation of mesenchymal cell proliferation), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0021587](http://purl.obolibrary.org/obo/GO_0021587) (cerebellum morphogenesis), [GO:0051973](http://purl.obolibrary.org/obo/GO_0051973) (positive regulation of telomerase activity), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:1903862](http://purl.obolibrary.org/obo/GO_1903862) (positive regulation of oxidative phosphorylation), [GO:0042474](http://purl.obolibrary.org/obo/GO_0042474) (middle ear morphogenesis), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0006865](http://purl.obolibrary.org/obo/GO_0006865) (amino acid transport), [GO:0005773](http://purl.obolibrary.org/obo/GO_0005773) (vacuole), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0006978](http://purl.obolibrary.org/obo/GO_0006978) (DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:0034644](http://purl.obolibrary.org/obo/GO_0034644) (cellular response to UV), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0031017](http://purl.obolibrary.org/obo/GO_0031017) (exocrine pancreas development), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0046722](http://purl.obolibrary.org/obo/GO_0046722) (lactic acid secretion), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0005657](http://purl.obolibrary.org/obo/GO_0005657) (replication fork), [GO:0070491](http://purl.obolibrary.org/obo/GO_0070491) (repressing transcription factor binding), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0002082](http://purl.obolibrary.org/obo/GO_0002082) (regulation of oxidative phosphorylation), [GO:2001171](http://purl.obolibrary.org/obo/GO_2001171) (positive regulation of ATP biosynthetic process), [GO:0042771](http://purl.obolibrary.org/obo/GO_0042771) (intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator), [GO:0021953](http://purl.obolibrary.org/obo/GO_0021953) (central nervous system neuron differentiation), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0019087](http://purl.obolibrary.org/obo/GO_0019087) (transformation of host cell by virus), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0021707](http://purl.obolibrary.org/obo/GO_0021707) (cerebellar granule cell differentiation), [GO:0008630](http://purl.obolibrary.org/obo/GO_0008630) (intrinsic apoptotic signaling pathway in response to DNA damage), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0043085](http://purl.obolibrary.org/obo/GO_0043085) (positive regulation of catalytic activity), [GO:0016485](http://purl.obolibrary.org/obo/GO_0016485) (protein processing), [GO:0071526](http://purl.obolibrary.org/obo/GO_0071526) (semaphorin-plexin signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0031065](http://purl.obolibrary.org/obo/GO_0031065) (positive regulation of histone deacetylation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090398](http://purl.obolibrary.org/obo/GO_0090398) (cellular senescence), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0045821](http://purl.obolibrary.org/obo/GO_0045821) (positive regulation of glycolytic process), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0000320](http://purl.obolibrary.org/obo/GO_0000320) (re-entry into mitotic cell cycle), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0010918](http://purl.obolibrary.org/obo/GO_0010918) (positive regulation of mitochondrial membrane potential), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:2000779](http://purl.obolibrary.org/obo/GO_2000779) (regulation of double-strand break repair), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0051262](http://purl.obolibrary.org/obo/GO_0051262) (protein tetramerization), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0001783](http://purl.obolibrary.org/obo/GO_0001783) (B cell apoptotic process), [GO:0044195](http://purl.obolibrary.org/obo/GO_0044195) (nucleoplasmic reticulum), [GO:0051276](http://purl.obolibrary.org/obo/GO_0051276) (chromosome organization), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0001658](http://purl.obolibrary.org/obo/GO_0001658) (branching involved in ureteric bud morphogenesis), [GO:0016604](http://purl.obolibrary.org/obo/GO_0016604) (nuclear body), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0043388](http://purl.obolibrary.org/obo/GO_0043388) (positive regulation of DNA binding), [GO:0006006](http://purl.obolibrary.org/obo/GO_0006006) (glucose metabolic process), [GO:0032091](http://purl.obolibrary.org/obo/GO_0032091) (negative regulation of protein binding), [GO:0035914](http://purl.obolibrary.org/obo/GO_0035914) (skeletal muscle cell differentiation), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016055](http://purl.obolibrary.org/obo/GO_0016055) (Wnt signaling pathway), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0033613](http://purl.obolibrary.org/obo/GO_0033613) (activating transcription factor binding), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0070888](http://purl.obolibrary.org/obo/GO_0070888) (E-box binding), [GO:0061484](http://purl.obolibrary.org/obo/GO_0061484) (hematopoietic stem cell homeostasis), [GO:0043279](http://purl.obolibrary.org/obo/GO_0043279) (response to alkaloid), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0007346](http://purl.obolibrary.org/obo/GO_0007346) (regulation of mitotic cell cycle), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0048730](http://purl.obolibrary.org/obo/GO_0048730) (epidermis morphogenesis), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:0010165](http://purl.obolibrary.org/obo/GO_0010165) (response to X-ray), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005138](http://purl.obolibrary.org/obo/GO_0005138) (interleukin-6 receptor binding), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0071074](http://purl.obolibrary.org/obo/GO_0071074) (eukaryotic initiation factor eIF2 binding), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0016032](http://purl.obolibrary.org/obo/GO_0016032) (viral process), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0032986](http://purl.obolibrary.org/obo/GO_0032986) (protein-DNA complex disassembly), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0035457](http://purl.obolibrary.org/obo/GO_0035457) (cellular response to interferon-alpha), [GO:1902262](http://purl.obolibrary.org/obo/GO_1902262) (apoptotic process involved in blood vessel morphogenesis), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0035690](http://purl.obolibrary.org/obo/GO_0035690) (cellular response to drug), [GO:0046325](http://purl.obolibrary.org/obo/GO_0046325) (negative regulation of glucose import), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0006352](http://purl.obolibrary.org/obo/GO_0006352) (DNA-templated transcription, initiation), [GO:1901857](http://purl.obolibrary.org/obo/GO_1901857) (positive regulation of cellular respiration), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0051597](http://purl.obolibrary.org/obo/GO_0051597) (response to methylmercury), [GO:0031647](http://purl.obolibrary.org/obo/GO_0031647) (regulation of protein stability), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0005819](http://purl.obolibrary.org/obo/GO_0005819) (spindle), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 54.61%
- [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex) 50.96%
- [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex) 50.96%
- [GO:0097517](http://purl.obolibrary.org/obo/GO_0097517) (contractile actin filament bundle) 50.96%
- [GO:0071456](http://purl.obolibrary.org/obo/GO_0071456) (cellular response to hypoxia) 50.96%
- [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound) 50.96%
- [GO:0044195](http://purl.obolibrary.org/obo/GO_0044195) (nucleoplasmic reticulum) 50.96%
- [GO:0042641](http://purl.obolibrary.org/obo/GO_0042641) (actomyosin) 50.96%
- [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex) 50.96%
- [GO:0032432](http://purl.obolibrary.org/obo/GO_0032432) (actin filament bundle) 50.96%
- [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface) 50.96%
- [GO:0005791](http://purl.obolibrary.org/obo/GO_0005791) (rough endoplasmic reticulum) 50.96%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 50.96%
- [GO:0005719](http://purl.obolibrary.org/obo/GO_0005719) (nuclear euchromatin) 50.96%
- [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm) 50.96%


